-->
-->
Market share based on U.S. sales (in dollars). There's no panacea in prescription drugs, so the industry is greatly fragmented. The top seller, cholesterol drug Lipitor, accounted for 2.7% of 2008 prescription-drug sales. Its marketer, Pfizer, led the industry in 2008 with a 7.0% market share.

Click sobre imagen para ampliar.
-->
1. Three other drugs had a 1.1% share in 2008: Prevacid (Takeda Pharmaceutical Co.); Abilify (co-marketed by Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co.); and Remicade (Johnson & Johnson's Centocor Ortho Biotech).
Source: IMS Health (sales).
No hay comentarios:
Publicar un comentario